Cargando…

The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues

Mesenchymal stem cell (MSC) transplantation is a novel treatment for liver diseases due to the roles of MSCs in regeneration, fibrosis inhibition and immune regulation. However, the mechanisms are still not completely understood. Despite the significant efficacy of MSC therapy in animal models and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ya, Zhao, Yalei, Zhang, Lingjian, Zhang, Fen, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200416/ https://www.ncbi.nlm.nih.gov/pubmed/34136500 http://dx.doi.org/10.3389/fmed.2021.655268

Ejemplares similares

Serum CXCL1 Is a Prognostic Factor for Patients With Hepatitis B Virus–Related Acute-On-Chronic Liver Failure
por: Xiao, Lanlan, et al.
Publicado: (2021)

COVID-19 in Elderly Adults: Clinical Features, Molecular Mechanisms, and Proposed Strategies
por: Yang, Ya, et al.
Publicado: (2020)

Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis
por: Yang, Ya, et al.
Publicado: (2022)

Low Growth Hormone Levels Predict Poor Outcome of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
por: Wu, Daxian, et al.
Publicado: (2021)

The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
por: Zhang, Sainan, et al.
Publicado: (2020)

SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma
por: Hu, Qingqing, et al.
Publicado: (2022)

1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure
por: Zhang, Lingjian, et al.
Publicado: (2022)

Knockdown of CXCL1 improves ACLF by reducing neutrophil recruitment to attenuate ROS production and hepatocyte apoptosis
por: Tang, Shima, et al.
Publicado: (2023)

Understanding the Unique Microenvironment in the Aging Liver
por: Zhao, Yalei, et al.
Publicado: (2022)

Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease
por: Yuan, Mengqin, et al.
Publicado: (2022)

Identification of a Potential miRNA–mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

Corrigendum: Identification of a Potential miRNA-mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/mitogen‐activated protein kinase and TLR4/nuclear factor‐κB pathways and autophagy
por: Zhang, Lingjian, et al.
Publicado: (2019)

Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Transplantation of mesenchymal stem cells and their derivatives effectively promotes liver regeneration to attenuate acetaminophen-induced liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Characterization of an Artificial Liver Support System-Related Vasovagal Reaction
por: Ma, Shanshan, et al.
Publicado: (2020)

A pooled analysis of mesenchymal stem cell-based therapy for liver disease
por: Zhao, Lu, et al.
Publicado: (2018)

Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
por: Moll, Guido, et al.
Publicado: (2020)

Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury
por: Xie, Zhongyang, et al.
Publicado: (2021)

Advances in RNA cytosine-5 methylation: detection, regulatory mechanisms, biological functions and links to cancer
por: Xue, Chen, et al.
Publicado: (2020)

Strategies for the induction of anti-inflammatory mesenchymal stem cells and their application in the treatment of immune-related nephropathy
por: Zhou, Cheng, et al.
Publicado: (2022)

Comprehensive immune cell analysis of human menstrual-blood-derived stem cells therapy to concanavalin A hepatitis
por: Zhang, Fen, et al.
Publicado: (2022)

The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation
por: Hu, Chenxia, et al.
Publicado: (2019)

A comparative study of Mesenchymal Stem Cells transplantation approach to antagonize age-associated ovarian hypofunction with consideration of safety and efficiency
por: Wang, Lingjuan, et al.
Publicado: (2021)

Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
por: Tang, Lingling, et al.
Publicado: (2020)

The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review
por: Zhang, Lei, et al.
Publicado: (2021)

Amnion-Derived Mesenchymal Stromal/Stem Cell Paracrine Signals Potentiate Human Liver Organoid Differentiation: Translational Implications for Liver Regeneration
por: Lo Nigro, Antonio, et al.
Publicado: (2021)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

The pathological and therapeutic roles of mesenchymal stem cells in preeclampsia
por: Jin, Sanshan, et al.
Publicado: (2022)

Safety and efficacy of human umbilical cord mesenchymal stem cells for the treatment of sepsis induced by pneumonia: study protocol for a single-centre, randomised single-blind parallel group trial
por: Wang, Chunxue, et al.
Publicado: (2022)

Safety of Mesenchymal Stem Cells for Clinical Application
por: Wang, Youwei, et al.
Publicado: (2012)

Regulation of autophagy protects against liver injury in liver surgery‐induced ischaemia/reperfusion
por: Hu, Chenxia, et al.
Publicado: (2021)

Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure
por: Wang, Jie, et al.
Publicado: (2017)

Safety and efficacy of the mesenchymal stem cell in feline eosinophilic keratitis treatment
por: Villatoro, Antonio J., et al.
Publicado: (2018)

Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: a protocol for a randomised controlled trial
por: Yang, Yuanjun, et al.
Publicado: (2022)

The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment
por: Chang, Yuqian, et al.
Publicado: (2022)

Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis
por: Lu, Wenming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ldjfvcvvilo2qc2ot6ui0tjilp